Artwork

Content provided by Wall Street Resource, LLC, Wall Street Resource, and LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wall Street Resource, LLC, Wall Street Resource, and LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

MIRA Pharmaceuticals, Inc. Erez Aminov, CEO

14:24
 
Distribuie
 

Manage episode 373264159 series 2612480
Content provided by Wall Street Resource, LLC, Wall Street Resource, and LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wall Street Resource, LLC, Wall Street Resource, and LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

MIRA is developing a new

molecular synthetic THC analog called MIRA1a, designed for the treatment of

adult patients with anxiety and cognitive decline, typically associated with

early-stage dementia.

MIRA’s initial focus will

be a dual path: potentially winning in traditional pain and anxiety markets as

well as the marijuana analog markets with a potentially safe and effective option if approved

by the FDA.

  continue reading

155 episoade

Artwork
iconDistribuie
 
Manage episode 373264159 series 2612480
Content provided by Wall Street Resource, LLC, Wall Street Resource, and LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wall Street Resource, LLC, Wall Street Resource, and LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

MIRA is developing a new

molecular synthetic THC analog called MIRA1a, designed for the treatment of

adult patients with anxiety and cognitive decline, typically associated with

early-stage dementia.

MIRA’s initial focus will

be a dual path: potentially winning in traditional pain and anxiety markets as

well as the marijuana analog markets with a potentially safe and effective option if approved

by the FDA.

  continue reading

155 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință